Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has been linked to a higher risk of mortality compared to influenza, which is mainly due to severe secondary diseases, such as acute respiratory distress syndrome (ARDS). In turn, ARDS is characterized by an acute inflammation an...

Descripción completa

Detalles Bibliográficos
Autores principales: Paar, Vera, Wernly, Bernhard, Zhou, Zhichao, Motloch, Lukas J., Hoppe, Uta C., Egle, Alexander, Lichtenauer, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338133/
https://www.ncbi.nlm.nih.gov/pubmed/32632558
http://dx.doi.org/10.1007/s11239-020-02212-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338133/
https://www.ncbi.nlm.nih.gov/pubmed/32632558
http://dx.doi.org/10.1007/s11239-020-02212-6

Ejemplares similares